Mercer Global Advisors
IBRN icon

Mercer Global Advisors’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Mercer Global Advisors’s Portfolio IBRN Stock Details IBRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
+2,700
New +$94.7K ﹤0.01% 3805

Other funds holding IBRN

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Mercer Global Advisors's IBRN Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in iShares Neuroscience and Healthcare ETF (IBRN) in Q2 2026: 2,700 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #3805 among its holdings.

6 funds tracked by Wall St. Rank hold IBRN as of Q2 2026.

  • Mercer Global Advisors held 2,700 shares of iShares Neuroscience and Healthcare ETF worth $105K as of Q2 2026.
  • iShares Neuroscience and Healthcare ETF was a new Mercer Global Advisors position in Q2 2026.
  • iShares Neuroscience and Healthcare ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3805 holding.
  • 6 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.